Gazyva: Interim Phase III data

Interim data from 1,202 patients with previously untreated follicular lymphoma in the open-label, international Phase III GALLIUM trial showed that Gazyva plus chemotherapy followed by Gazyva

Read the full 264 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE